Subcutaneous rifampicin versus povidone-iodine for the prevention of incisional surgical site infections following gynecologic oncology surgery - a prospective, randomized, controlled trial.
Hüseyin Çağlayan ÖzcanÖzcan BalatPublished in: Ginekologia polska (2021)
Subcutaneous agents are not effective in preventing surgical site infections after gynecologic oncology surgeries. Further large-scale prospective randomized controlled studies may provide other options to prevent SSIs.
Keyphrases
- randomized controlled trial
- palliative care
- minimally invasive
- surgical site infection
- double blind
- study protocol
- open label
- endometrial cancer
- coronary artery bypass
- mycobacterium tuberculosis
- placebo controlled
- phase iii
- phase ii
- clinical trial
- systematic review
- magnetic resonance
- case control
- coronary artery disease